MedTrace Logo

Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge

NCT01171404 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10568

Last updated 2013-04-17

No results posted yet for this study

Summary

The aim of this international study is to describe the short- and long-term (i.e. up to 2 years following the index event) antithrombotic management patterns (AMPs) in patients hospitalized for acute coronary syndromes (ST segment elevation myocardial infarction (STEMI), Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS)), and to document the impact of AMPs in clinical outcomes, economic variables and quality of life in a 'real-life' setting and to compare these between sites, countries and regions.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Mónica Tafalla · Medical Department.AstraZeneca Spain

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • Argentina
  • Belgium
  • Brazil
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Italy
  • Luxembourg
  • Mexico
  • Netherlands
  • Norway
  • Poland
  • Romania
  • Slovenia
  • Spain
  • Turkey (Türkiye)
  • United Kingdom
  • Venezuela

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01171404 on ClinicalTrials.gov